- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips unveils tiniest TEE probe
Other headlines:eRAD boosts interoperability of PACS
Philips unveils tiniest TEE probe
Philips claimed the world's smallest transesophageal echocardiography (TEE) transducer this week at the American Society of Echocardiography. Its newly unveiled microTEE, which is about one-third the size of pediatric TEE transducers now on the market, was developed specifically for cardiac imaging of neonatal patients too small for other such probes. The microTEE will be available for sale globally this summer as part of the company's latest Vision release for the Philips iE33 intelligent echocardiography system. Although particularly suited to small neonates, the microTee may also help adult patients who have trouble tolerating standard-size TEE probes.
eRAD boosts interoperability of PACS
PACS/IT vendor eRAD has upgraded its eRAD RIS/PACS v6 with a new web-based platform designed to integrate images, reports, and other data from information systems built by other vendors. The new uniRAD can be customized to fit specific preferences at the site, while offering the flexibility to accommodate a range of external systems. Initial installations of the new platform are in place in the U.S. and Hungary.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
